IWATE MEDICAL UNIVERSITY
π―π΅Japan
- Country
- π―π΅Japan
- Ownership
- Private
- Established
- 1901-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.iwate-med.ac.jp
Comparison of MECHANISM of Early and Late Vascular Responses Following Treatment of ST-elevation Acute Myocardial Infarction With Two Different Everolimus-eluting Stents: Randomized Controlled Trial Between Biodegradable Polymer and Durable Polymer Stent (MECHANISM-AMI-RCT)
Not Applicable
- Conditions
- Coronary Artery Disease
- Interventions
- Device: PCI
- First Posted Date
- 2018-11-01
- Last Posted Date
- 2020-06-02
- Lead Sponsor
- Iwate Medical University
- Target Recruit Count
- 120
- Registration Number
- NCT03726892
- Locations
- π―π΅
Iwate Medical University Hospital, Morioka, Japan
Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent and Platelet AggregatioN studIeS for TreatMent of Acute Myocardial InfarctionTreatment of ST-elevation Acute Myocardial Infarction
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: cobalt-chromium everolimus-eluting stent (CoCr-EES)
- First Posted Date
- 2013-12-18
- Last Posted Date
- 2019-03-19
- Lead Sponsor
- Iwate Medical University
- Target Recruit Count
- 100
- Registration Number
- NCT02014753
- Locations
- π―π΅
Iwate Medical University Hospital, Morioka, Japan
Predictive Biomarkers in Stage II/III Gastric Cancer for Adjuvant Chemotherapy
- Conditions
- Gastric Cancer
- First Posted Date
- 2013-07-23
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- Iwate Medical University
- Target Recruit Count
- 500
- Registration Number
- NCT01905969
- Locations
- π―π΅
Iwate Medical University School of Medicine, Morioka, Iwate, Japan
Novel Peptide Vaccination for Patients With Advanced Renal Cell Carcinoma
Phase 1
Completed
- Conditions
- Renal Cell Carcinoma
- First Posted Date
- 2010-12-07
- Last Posted Date
- 2010-12-07
- Lead Sponsor
- Iwate Medical University
- Registration Number
- NCT01254838
Novel Peptide Vaccination for Patients With Advanced Prostate Cancer
Phase 1
- Conditions
- Prostate Cancer
- First Posted Date
- 2010-10-21
- Last Posted Date
- 2011-06-23
- Lead Sponsor
- Iwate Medical University
- Target Recruit Count
- 30
- Registration Number
- NCT01225471
- Locations
- π―π΅
Iwate Medical University School of Medicine, Morioka, Iwate, Japan
Novel Peptide Vaccination for Patients With Advanced Bladder Cancer
Phase 1
Completed
- Conditions
- Bladder Cancer
- First Posted Date
- 2008-03-13
- Last Posted Date
- 2010-10-21
- Lead Sponsor
- Iwate Medical University
- Target Recruit Count
- 20
- Registration Number
- NCT00635336
- Locations
- π―π΅
Iwate Medical University School of Medicine, Morioka, Iwate, Japan
Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder Cancer
Phase 2
- Conditions
- Bladder Cancer
- First Posted Date
- 2008-03-11
- Last Posted Date
- 2011-06-23
- Lead Sponsor
- Iwate Medical University
- Target Recruit Count
- 150
- Registration Number
- NCT00633204
- Locations
- π―π΅
Iwate Medical University School of Medicine, Morioka, Iwate, Japan
Uracil and Tegafur/Leucovorin (UFT/LV) Versus UFT/LV+ Polysaccharide-K (PSK) for Stage IIIa/IIIb Colorectal Cancer
Phase 3
- Conditions
- Colorectal Cancer
- Interventions
- First Posted Date
- 2007-07-06
- Last Posted Date
- 2008-07-31
- Lead Sponsor
- Iwate Medical University
- Target Recruit Count
- 300
- Registration Number
- NCT00497107
- Locations
- π―π΅
Iwate Medical University Hospital, Morioka, Iwate, Japan
Β© Copyright 2025. All Rights Reserved by MedPath